Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Outpatient Administration of High Dose BEAM Chemotherapy As Conditioning for Autologous Stem Cell Transplantation for Lymphoma Results in Fewer Infectious Complications and Improved Survival

Robin M. Reid, MD, Andrea Baran, MS, Paul M. Barr, MD, Michael W. Becker, MD, Steven H. Bernstein, MD, Jonathan W. Friedberg, MD, Jane L. Liesveld, MD, Gordon L. Phillips, MD, Lucy Wedow, FNP, Laurie A. Milner, MD

Blood (2014) 124 (21): 3984.

https://doi.org/10.1182/blood.V124.21.3984.3984

Published: 2014

Journal Articles

Phase I Study of Decitabine and Rapamycin in Relapsed/Refractory Acute Myelogenous Leukemia

Jane L. Liesveld, MD, Kristen O'Dwyer, MD, Michael W. Becker, MD, Deborah Mulford, MD, Alison Walker, MD, Rui Chen, PhD, Jeremy Bechelli, MS, Karen Rosell, BS, Craig T. Jordan, PhD, Mohammad Minhajuddin, PhD, Gordon L. Phillips, II, MD

Blood (2012) 120 (21): 3549.

https://doi.org/10.1182/blood.V120.21.3549.3549

Published: 2012

Journal Articles

Randomized Comparison of Melphalan 200 Mg/m 2 v. 280 Mg/m 2 As a Preparative Regimen for Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation

William I. Bensinger, MD, Pamela S Becker, MD, PhD, Ted A. Gooley, PhD, Thomas Chauncey, MD, PhD, David G. Maloney, MD, PhD, Robert Vescio, MD, Ajay K. Gopal, MD, Damian J. Green, MD, Oliver W. Press, MD, PhD, Michael Lill, M.D., Leona Holmberg, MD, PhD, Jainulabdeen J Ifthikharuddin, MD, Gordon L. Phillips, II, MD

Blood (2012) 120 (21): 2009.

https://doi.org/10.1182/blood.V120.21.2009.2009

Published: 2012

Journal Articles

Phase I Study of Eltrombopag for Promoting Thrombopoiesis in Patients Undergoing Stem Cell Transplantation After Total Body Irradiation

Jane L. Liesveld, MD, Gordon L. Phillips, II, MD, Michael W. Becker, MD, Louis Constine, MD, Jonathan W. Friedberg, MD, Jeffrey Andolina, MD, MS, Laurie Milner, MD, Therese Smudzin, Ollivier Hyrien, PhD, Katie L Dawson, MD, MPH, Yuhchyau Chen, MD, PhD

Blood (2012) 120 (21): 219.

https://doi.org/10.1182/blood.V120.21.219.219

Published: 2012

Journal Articles

Phase I Study of Eltrombopag for Promoting Thrombopoiesis in Patients Undergoing Stem Cell Transplantation After Total Body Irradiation,

Jane L. Liesveld, MD, Gordon L. Phillips, II, MD, Michael W. Becker, MD, Louis Constine, MD, Jonathan Friedberg, MD, Jeffrey Andolina, MD, MS, Laurie Milner, MD, Jessica DeBolt, Ollivier Hyrien, PhD, Katie L Dawson, MD, MPH, Yuhchyau Chen, MD, PhD

Blood (2011) 118 (21): 3295.

https://doi.org/10.1182/blood.V118.21.3295.3295

Published: 2011

Journal Articles

Impact of Clinical Factors on Platelet Engraftments In Contemporary Stem Cell Transplantation.

Jane L. Liesveld, MD, Rui Chen, Joseph Pawlowski, Jessica Debolt, Michael Becker, Louis Constine, Gordon L. Phillips, II, MD, Ollivier Hyrien, Yuhchyau Chen

Blood (2010) 116 (21): 4522.

https://doi.org/10.1182/blood.V116.21.4522.4522

Published: 2010

Journal Articles

Blood CD34 Levels as a Predictor of Successful Peripheral Blood Stem Cell Mobilization In Consecutive Autologous Stem Cell Apheresis Patients From a Single Transplant Center

Sujatha Mogili, Rui Chen, Michael Becker, Faith Young, Gordon L. Phillips, II, MD, Sue Frauenhofer, Donna Cimbalo, Sean Czaja, Diane Nichols, Jane L. Liesveld, MD

Blood (2010) 116 (21): 4440.

https://doi.org/10.1182/blood.V116.21.4440.4440

Published: 2010

Journal Articles

The Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI) and Survival After Extracorporeal Photopheresis, Pentostatin, and Reduced Dose Total Body Irradiation (TUFTs) Conditioning Prior to Allogeneic Stem Cell Transplantation (SCT)

Shahrukh Hashmi, MD, MPH, Jamie L Oliva, MS, NP, Jane L. Liesveld, MD, Gordon L. Phillips, II, MD, Diane Nichols, Michael Becker, MD

Blood (2010) 116 (21): 1337.

https://doi.org/10.1182/blood.V116.21.1337.1337

Published: 2010

Journal Articles

Salvage Autologous Hematpoeitic Stem Cell Transplants (AHSCT2) for Myeloma: Single Center Experience.

Bishoy Faltas, MD, Jane L. Liesveld, MD, Michael Becker, Jainulabdeen J. Ifthikharuddin, MD, Gordon L. Phillips, II, MD

Blood (2010) 116 (21): 4591.

https://doi.org/10.1182/blood.V116.21.4591.4591

Published: 2010

Journal Articles

High-Dose Therapy and Autologous Stem Cell Transplant (HD-ASCT) for Transformed Non-Hodgkin Lymphoma (NHL) In the Rituximab Era

Makiko Ban-Hoefen, MD, Jonathan W. Friedberg, MD, Jennifer L. Kelly, PhD, MPH, Steven H. Bernstein, MD, Jane L. Liesveld, MD, Faith Young, MD, Richard I Fisher, MD, Louis Constine, MD, Michael Becker, MD, Gordon L. Phillips, II, MD

Blood (2010) 116 (21): 2393.

https://doi.org/10.1182/blood.V116.21.2393.2393

Published: 2010

Journal Articles

Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia

Blood (2010) 115 (9): 1850–1857.

https://doi.org/10.1182/blood-2009-10-249128

Published: 2010

Journal Articles

A Phase I study using Bortezomib with Weekly Idarubicin for the Treatment of Elderly (>60 YEARS) and Relapsed Patients with Acute Myeloid Leukemia (AML)

Dianna Howard, MD, Jane Liesveld, MD, Gordon L. Phillips, II, MD, Monica L. Guzman, PhD, Craig T. Jordan, PhD

Blood (2008) 112 (11): 2953.

https://doi.org/10.1182/blood.V112.11.2953.2953

Published: 2008

Journal Articles

Phase I Study of Cladribine, Cytarabine (Ara-C), Granulocyte Colony Stimulating Factor (G-CSF) (CLAG Regimen) and Simultaneous Escalating Doses of Imatinib Mesylate (Gleevec) in Relapsed/Refractory AML.

Camille N. Abboud, MD, Alison Walker, MD, Rami S. Komrokji, MD, Jainulabdeen J. Ifthikharuddin, MD, Connie Sparks, BS,CRA, Kelly Likly, MSN, Patti Messina, BSN, Deborah Mulford, MD, Jonathan Friedberg, MD, Michael W. Becker, MD, Faith Young, MD, Steven H. Bernstein, MD, August J. Salvado, MD, Gordon L. Phillips, MD, Jane L. Liesveld, MD

Blood (2006) 108 (11): 1958.

https://doi.org/10.1182/blood.V108.11.1958.1958

Published: 2006

Journal Articles

Phase I Study for Poor Prognosis Lymphoma: Modification of the “BEAM” (BCNU +Etoposide+ARA-C+Melphalan) Regimen with Escalating-Dose Melphalan (MEL) Using Amifostine (AF) Cytoprotection and Autologous Hematopoietic Stem Cell Transplantation (AHSCT).

Gordon L. Phillips, MD, Camille N. Abboud, MD, Steven H. Bernstein, MD, Jonathan W. Friedberg, MD, Michael W. Becker, MD, Jainulabdeen J. Ifthikharuddin, MD, Faith Young, MD, Jane L. Liesveld, MD

Blood (2006) 108 (11): 3076.

https://doi.org/10.1182/blood.V108.11.3076.3076

Published: 2006

Journal Articles

Extracorporeal Photopheresis, Pentostatin, and TBI for Reduced-Intensity Preparation: Adaptation of the Tufts Experience at a Single Transplant Center.

Jane L. Liesveld, MD, Camille N. Abboud, MD, Stephen H. Bernstein, MD, Jonathan Friedberg, MD, Jainulabdeen J. Ifthikharuddin, MD, Louis S. Constine, MD, Karen L. Kaplan, MD, PhD, Lucy A. Wedow N.P., Diane D. Nichols, BS, Jamie Oliva, N.P., Maryanne Etter, N.P, Gordon L. Phillips, MD

Blood (2005) 106 (11): 5417.

https://doi.org/10.1182/blood.V106.11.5417.5417

Published: 2005

Journal Articles

High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver

Julye C. Lavoie, Joseph M. Connors, Gordon L. Phillips, Donna E. Reece, Michael J. Barnett, Donna L. Forrest, Randy D. Gascoyne, Donna E. Hogge, Stephen H. Nantel, John D. Shepherd, Clayton A. Smith, Kevin W. Song, Heather J. Sutherland, Cynthia L. Toze, Nicholas J. S. Voss, Thomas J. Nevill

Blood (2005) 106 (4): 1473–1478.

https://doi.org/10.1182/blood-2004-12-4689

Published: 2005

Journal Articles

The CXCR4 Antagonist, AMD3100, Inhibits AML Transmigratory Activity but Does Not Alter Blast Proliferation or Survival.

Jane L. Liesveld, MD, Jeffrey E. Lancet, MD, Karen E. Rosell, BS, Jeremy Bechelli, BS, Camille N. Abboud, MD, Gordon L. Phillips, II, MD

Blood (2004) 104 (11): 2881.

https://doi.org/10.1182/blood.V104.11.2881.2881

Published: 2004

Journal Articles

Incidence and Risk Factors for Thromboembolism in Patients with Hematologic Malignancies Undergoing Allogeneic and Autologous Stem Cell Transplantation.

Nicole M. Kuderer, MD, Alok A. Khorana, MD, Jonathan W. Friedberg, MD, Eva Culakova, PhD, Gordon L. Phillips, MD, Charles W. Francis, MD, Gary H. Lyman, MD, MPH

Blood (2004) 104 (11): 1141.

https://doi.org/10.1182/blood.V104.11.1141.1141

Published: 2004

Journal Articles

Is the cure worse than the disease?

Gordon L. Phillips, II

Blood (2003) 101 (5): 1666–1667.

https://doi.org/10.1182/blood-2003-01-0052

Published: 2003

Journal Articles

Expression of tumor-suppressor genes interferon regulatory factor 1 and death-associated protein kinase in primitive acute myelogenous leukemia cells

Monica L. Guzman, Donna Upchurch, Barry Grimes, Dianna S. Howard, David A. Rizzieri, Selina M. Luger, Gordon L. Phillips, Craig T. Jordan

Blood (2001) 97 (7): 2177–2179.

https://doi.org/10.1182/blood.V97.7.2177

Published: 2001

NARROW

Outpatient Administration of High Dose BEAM Chemotherapy As Conditioning for Autologous Stem Cell Transplantation for Lymphoma Results in Fewer Infectious Complications and Improved Survival

Phase I Study of Decitabine and Rapamycin in Relapsed/Refractory Acute Myelogenous Leukemia

Randomized Comparison of Melphalan 200 Mg/m 2 v. 280 Mg/m 2 As a Preparative Regimen for Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation

Phase I Study of Eltrombopag for Promoting Thrombopoiesis in Patients Undergoing Stem Cell Transplantation After Total Body Irradiation

Phase I Study of Eltrombopag for Promoting Thrombopoiesis in Patients Undergoing Stem Cell Transplantation After Total Body Irradiation,

Impact of Clinical Factors on Platelet Engraftments In Contemporary Stem Cell Transplantation.

Blood CD34 Levels as a Predictor of Successful Peripheral Blood Stem Cell Mobilization In Consecutive Autologous Stem Cell Apheresis Patients From a Single Transplant Center

The Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI) and Survival After Extracorporeal Photopheresis, Pentostatin, and Reduced Dose Total Body Irradiation (TUFTs) Conditioning Prior to Allogeneic Stem Cell Transplantation (SCT)

Salvage Autologous Hematpoeitic Stem Cell Transplants (AHSCT2) for Myeloma: Single Center Experience.

High-Dose Therapy and Autologous Stem Cell Transplant (HD-ASCT) for Transformed Non-Hodgkin Lymphoma (NHL) In the Rituximab Era

Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia

A Phase I study using Bortezomib with Weekly Idarubicin for the Treatment of Elderly (>60 YEARS) and Relapsed Patients with Acute Myeloid Leukemia (AML)

Phase I Study of Cladribine, Cytarabine (Ara-C), Granulocyte Colony Stimulating Factor (G-CSF) (CLAG Regimen) and Simultaneous Escalating Doses of Imatinib Mesylate (Gleevec) in Relapsed/Refractory AML.

Phase I Study for Poor Prognosis Lymphoma: Modification of the “BEAM” (BCNU +Etoposide+ARA-C+Melphalan) Regimen with Escalating-Dose Melphalan (MEL) Using Amifostine (AF) Cytoprotection and Autologous Hematopoietic Stem Cell Transplantation (AHSCT).

Extracorporeal Photopheresis, Pentostatin, and TBI for Reduced-Intensity Preparation: Adaptation of the Tufts Experience at a Single Transplant Center.

High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in Vancouver

The CXCR4 Antagonist, AMD3100, Inhibits AML Transmigratory Activity but Does Not Alter Blast Proliferation or Survival.

Incidence and Risk Factors for Thromboembolism in Patients with Hematologic Malignancies Undergoing Allogeneic and Autologous Stem Cell Transplantation.

Is the cure worse than the disease?

Expression of tumor-suppressor genes interferon regulatory factor 1 and death-associated protein kinase in primitive acute myelogenous leukemia cells

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only